Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

61.

Rwanda 20 years on: investing in life.

Lancet.
Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, Ngabo F, Wagner CM, Nutt CT, Nyatanyi T, Gatera M, Kayiteshonga Y, Mugeni C, Mugwaneza P, Shema J, Uwaliraye P, Gaju E, Muhimpundu MA, Dushime T, Senyana F, Mazarati JB, Gaju CM, Tuyisenge L, Mutabazi V, Kyamanywa P, Rusanganwa V, Nyemazi JP, Umutoni A, Kankindi I, Ntizimira C, Ruton H, Mugume N, Nkunda D, Ndenga E, Mubiligi JM, Kakoma JB, Karita E, Sekabaraga C, Rusingiza E, Rich ML, Mukherjee JS, Rhatigan J, Cancedda C, Bertrand-Farmer D, Bukhman G, Stulac SN, Tapela NM, van der Hoof Holstein C, Shulman LN, Habinshuti A, Bonds MH, Wilkes MS, Lu C, Smith-Fawzi MC, Swain JD, Murphy MP, Ricks A, Kerry VB, Bush BP, Siegler RW, Stern CS, Sliney A, Nuthulaganti T, Karangwa I, Pegurri E, Dahl O, Drobac PC.
| Jul 26, 2014
62.

A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.

Cell.
Gröschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BA, Erpelinck C, van der Velden VH, Havermans M, Avellino R, van Lom K, Rombouts EJ, van Duin M, Döhner K, Beverloo HB, Bradner JE, Döhner H, Löwenberg B, Valk PJ, Bindels EM, de Laat W, Delwel R.
| Apr 10, 2014
63.

Cancer: Clonal cooperation.

Nature.
Polyak K, Marusyk A.
| Apr 3, 2014
64.

Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy.

Nature.
Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC.
| May 1, 2014
65.

Thyroid hormone inactivation in gastrointestinal stromal tumors.

N. Engl. J. Med.
Maynard MA, Marino-Enriquez A, Fletcher JA, Dorfman DM, Raut CP, Yassa L, Guo C, Wang Y, Dorfman C, Feldman HA, Frates MC, Song H, Jugo RH, Taguchi T, Hershman JM, Larsen PR, Huang SA.
| Apr 3, 2014
66.

Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.

Nature.
Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D, Tsou P, Gan W, Papa A, Kim BM, Wan L, Singh A, Zhai B, Yuan M, Wang Z, Gygi SP, Lee TH, Lu KP, Toker A, Pandolfi PP, Asara JM, Kirschner MW, Sicinski P, Cantley L, Wei W.
| Apr 24, 2014
68.

The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells.

Nat. Immunol.
Kurachi M, Barnitz RA, Yosef N, Odorizzi PM, DiIorio MA, Lemieux ME, Yates K, Godec J, Klatt MG, Regev A, Wherry EJ, Haining WN.
| 03 02, 2014
69.

An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.

Nat. Genet.
Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG, Cotton MJ, Gillespie SM, Fernandez D, Ku M, Wang H, Piccioni F, Silver SJ, Jain M, Pearson D, Kluk MJ, Ott CJ, Shultz LD, Brehm MA, Greiner DL, Gutierrez A, Stegmaier K, Kung AL, Root DE, Bradner JE, Aster JC, Kelliher MA, Bernstein BE.
| 03 02, 2014
70.

ARID1B is a specific vulnerability in ARID1A-mutant cancers.

Nat. Med.
Helming KC, Wang X, Wilson BG, Vazquez F, Haswell JR, Manchester HE, Kim Y, Kryukov GV, Ghandi M, Aguirre AJ, Jagani Z, Wang Z, Garraway LA, Hahn WC, Roberts CW.
| 02 23, 2014
71.

A need for scalable outpatient palliative care interventions.

Lancet.
Block SD, Billings JA.
| May 17, 2014
72.

Regenerative biology: Take the brakes off for liver repair.

Nature.
Cox AG, Goessling W.
| Feb 20, 2014
73.

Defining success in neoadjuvant breast cancer trials.

Lancet.
Carey LA, Winer EP.
| Jul 12, 2014
74.

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.

Cell.
Croci DO, Cerliani JP, Dalotto-Moreno T, Méndez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, García-Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M, Rabinovich GA.
| Feb 13, 2014
75.

Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse.

Nature.
Choudhuri K, Llodrá J, Roth EW, Tsai J, Gordo S, Wucherpfennig KW, Kam LC, Stokes DL, Dustin ML.
| Mar 6, 2014
76.

In vivo discovery of immunotherapy targets in the tumour microenvironment.

Nature.
Zhou P, Shaffer DR, Alvarez Arias DA, Nakazaki Y, Pos W, Torres AJ, Cremasco V, Dougan SK, Cowley GS, Elpek K, Brogdon J, Lamb J, Turley SJ, Ploegh HL, Root DE, Love JC, Dranoff G, Hacohen N, Cantor H, Wucherpfennig KW.
| Feb 6, 2014
77.

Dividing cells regulate their lipid composition and localization.

Cell.
Atilla-Gokcumen GE, Muro E, Relat-Goberna J, Sasse S, Bedigian A, Coughlin ML, Garcia-Manyes S, Eggert US.
| Jan 30, 2014
78.

Strength in numbers: comparing vaccine signatures the modular way.

Nat. Immunol.
Haining WN.
| 1 23, 2014
79.

Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch.

Cell.
Cohen P, Levy JD, Zhang Y, Frontini A, Kolodin DP, Svensson KJ, Lo JC, Zeng X, Ye L, Khandekar MJ, Wu J, Gunawardana SC, Banks AS, Camporez JP, Jurczak MJ, Kajimura S, Piston DW, Mathis D, Cinti S, Shulman GI, Seale P, Spiegelman BM.
| Jan 16, 2014
80.

What we talk about when we talk about fat.

Cell.
Rosen ED, Spiegelman BM.
| Jan 16, 2014